Pharmacy

Last week, CHA shared information about problems some providers have had in implementing a new state law requiring controlled substance security prescription forms to include a unique serial number. This week, the California Board of Pharmacy released updated frequently asked questions about the law’s requirements and enforcement. 

As of Jan. 1, controlled substance security prescription forms must include a new, unique serial number in a format approved by the Department of Justice. However, the new requirement does not allow for a transition period during which providers would be allowed to use the previously approved form, and those who do not have access to the new forms have been forced to choose between denying care and risking action against their licenses.

Prescribers are now required to offer naloxone hydrochloride, or another drug approved by the Food and Drug Administration, to patients who experience certain conditions related to opioid depression. The Medical Board of California has released frequently asked questions to assist providers in implementing the new requirements, which took effect Jan. 1.